Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML

Clinical trial NCT04168502 · RECRUITING

Trial details

NCT number: NCT04168502
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2020-09-24
Primary completion: 2025-04-01
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.